Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
News
10 at 10: These ASX stocks are floating up this morning
Experts
ScoPo’s health powerplays: ‘Cannabis stocks went on a ride’
News
ScoPo’s powerplays: ‘Santa is smiling on the markets’
News
Last Orders: What you might have missed on the ASX today
Experts
ScoPo’s health powerplays: ‘We said October was going to be volatile’
Health & Biotech
Dimerix to progress DMX-200 to phase 3 trial to treat kidney disease FSGS
Health & Biotech
Dr Boreham’s Crucible: Is Suda back on track after securing first TGA approval?
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
Aussie cannabis industry set for painful shakeup – report
Experts
ScoPo’s health powerplays: Pot stocks get a boost
Health & Biotech
Zelira Therapeutics to launch cannabis-based toothpaste
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Guides
Cannabis stocks guide: Here’s everything you need to know
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
Health & Biotech
Medicinal cannabis manufacturing becomes a key focus for WA
News
Rise and Shine: What you need to know before the ASX opens
News
